| Literature DB >> 34555238 |
Juraj Konč1, Libby Brown1, Daniel R Whiten1, Yukun Zuo1, Peter Ravn2,3, David Klenerman1,4, Gonçalo J L Bernardes1,5.
Abstract
Many bioconjugation strategies for DNA oligonucleotides and antibodies suffer limitations, such as site-specificity, stoichiometry and hydrolytic instability of the conjugates, which makes them unsuitable for biological applications. Here, we report a new platform for the preparation of DNA-antibody bioconjugates with a simple benzoylacrylic acid pentafluorophenyl ester reagent. Benzoylacrylic-labelled oligonucleotides prepared with this reagent can be site-specifically conjugated to a range of proteins and antibodies through accessible cysteine residues. The homogeneity of the prepared DNA-antibody bioconjugates was confirmed by a new LC-MS protocol and the bioconjugate probes were used in fluorescence or super-resolution microscopy cell imaging experiments. This work demonstrates the versatility and robustness of our bioconjugation protocol that gives site-specific, well-defined and plasma-stable DNA-antibody bioconjugates for biological applications.Entities:
Keywords: antibodies; bioconjugation; imaging; mass spectrometry; nucleic acids
Mesh:
Substances:
Year: 2021 PMID: 34555238 PMCID: PMC9297960 DOI: 10.1002/anie.202109713
Source DB: PubMed Journal: Angew Chem Int Ed Engl ISSN: 1433-7851 Impact factor: 16.823